5657-41-0 Usage
General Description
4-(carbamoylamino)benzenesulfonamide is a chemical compound that belongs to the class of sulfonamides. It has a molecular formula of C7H9N3O3S and a molecular weight of 215.23 g/mol. 4-(carbamoylamino)benzenesulfonamide is commonly used as a pharmaceutical intermediate in the synthesis of various drugs, particularly antibiotics and antifungal agents. It works by inhibiting the synthesis of dihydrofolic acid in bacteria, thereby preventing the production of essential nucleic acids. 4-(carbamoylamino)benzenesulfonamide is also known for its anti-inflammatory properties and has been studied for its potential use in treating conditions such as rheumatoid arthritis and other inflammatory diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 5657-41-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,5 and 7 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 5657-41:
(6*5)+(5*6)+(4*5)+(3*7)+(2*4)+(1*1)=110
110 % 10 = 0
So 5657-41-0 is a valid CAS Registry Number.
5657-41-0Relevant articles and documents
Carbonic anhydrase inhibitors: Design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives
Pichake, Jayashree,Kharkar, Prashant S.,Ceruso, Mariangela,Supuran, Claudiu T.,Toraskar, Mrunmayee P.
, p. 793 - 796 (2014)
A series of novel sulfonyl semicarbazides 5-13 was designed, synthesized, and evaluated for human carbonic anhydrase (hCA) inhibition. The new sulfonyl semicarbazides were tested against a panel of hCA isoforms I, II, IX, and XII, using acetazolamide (AZA
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff's bases incorporating iminoureido moieties
Singasane, Namrata,Kharkar, Prashant S.,Ceruso, Mariangela,Supuran, Claudiu T.,Toraskar, Mrunmayee P.
, p. 901 - 907 (2015)
A series of new Schiff's bases was obtained from the sulfanilamide semicarbazone (4-aminosulfonylphenyl semicarbazide) and aromatic/heterocyclic aldehydes. The new compounds were designed to incorporate moieties known to induce effective inhibitory activi
